RxDoctor Payments Data

Matthew Ebinger, DO

Clinical Cardiac Electrophysiology · Detroit, MINPI 1225087448

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Medical Device Business Services, Inc. at 40.4% of the total. Reporting peaked in 2019 at $19,214 and has fallen 92.4% since, to $1,460 in 2025.

$36,160in general payments, 2019–2025

Across 192 payments — averaging $188.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$15K
  • Biosense Webster, Inc.$10K
  • Medtronic$9K
  • Boston Scientific$1K
  • Biotronik Inc.$377
  • Abbott$299
  • plus $561 from 12 others
$5,911in research payments, 2019–2025

Across 6 payments — averaging $985.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boehringer Ingelheim$4K
  • Abbott$2K

What the payments were for

  • Consulting fees$18,77552%
  • Travel & lodging$9,92527%
  • Food & beverage$7,46021%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,160 in reported general payments places this provider in the 65th percentile of 105 clinical cardiac electrophysiology providers in Michigan.

See all clinical cardiac electrophysiology providers in Michigan

Medicare billing

Part B allowed, 2024
$125,332
Medicare patients
359
Services billed
1,092

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban156$199,355
XareltoRivaroxaban26$40,321
Dofetilide49$7,989
Flecainide Acetate68$3,755
Amiodarone Hcl82$2,879
Diltiazem 24hr Er (Cd)Diltiazem Hcl23$943
Metoprolol Succinate50$927
Metoprolol Tartrate79$570
SotalolSotalol Hcl18$466
ClopidogrelClopidogrel Bisulfate12$208
Omeprazole12$183
Warfarin Sodium13$148

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$11$199,355156 claims
Johnson & JohnsonXarelto$20$40,32126 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 105 clinical cardiac electrophysiology providers in Michigan.

Other clinical cardiac electrophysiology in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →